Callisto Pharmaceuticals Opens Additional Site for Phase II … – PR Newswire (press Drug Alternatives release)
| Callisto Pharmaceuticals Opens Additional Site for Phase II … PR Newswire (press release), NY - … activity against resistant diseases and – Drug Alternatives – and significantly reduced cardiotoxicity, or damage ,( Drug Alternatives ) to the heart, compared to currently available drug alternatives. … |
